Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (791-800 of 1,132) with videos related to

Pageof 114
Sort By:
Journal of Pain and Symptom Management|February 11, 2026
Identifying Key Components of Neuropalliative Care Fellowship using Nominal Group TechniqueSachi Y Gianchandani, Jocelyn M Jiao, Kwame O Adjepong, et al.
Plos One|April 24, 2015
LucY: A Versatile New Fluorescent Reporter ProteinMichele E Auldridge, Hongnan Cao, Saurabh Sen, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Archives of Biochemistry and Biophysics|February 21, 2017
A scalable lysyl hydroxylase 2 expression system and luciferase-based enzymatic activity assayHou-Fu Guo, Eun Jeong Cho, Ashwini K Devkota, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Antiretroviral therapy for prevention of HIV transmission: implications for EuropeV Cambiano, J O'Connor, A N Phillips, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2009
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysisJ Delgado, S Pillai, N Phillips, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
Pageof 114

Showing results (791-800 of 1,132) with videos related to

Sort By:
Pageof 114
Journal of Pain and Symptom Management|February 11, 2026
Identifying Key Components of Neuropalliative Care Fellowship using Nominal Group TechniqueSachi Y Gianchandani, Jocelyn M Jiao, Kwame O Adjepong, et al.
Plos One|April 24, 2015
LucY: A Versatile New Fluorescent Reporter ProteinMichele E Auldridge, Hongnan Cao, Saurabh Sen, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Archives of Biochemistry and Biophysics|February 21, 2017
A scalable lysyl hydroxylase 2 expression system and luciferase-based enzymatic activity assayHou-Fu Guo, Eun Jeong Cho, Ashwini K Devkota, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Antiretroviral therapy for prevention of HIV transmission: implications for EuropeV Cambiano, J O'Connor, A N Phillips, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2009
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysisJ Delgado, S Pillai, N Phillips, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
Pageof 114